From: A mouse plasma peptide atlas as a resource for disease proteomics
Peptide | Counts | Percentage |
---|---|---|
Total assignment above threshold | 800,507 | Â |
Total correct assignment | 791,069 | Â |
Total incorrect assignment | 9,438 | Â |
Spectrum assignment false discovery rate | 0.012 | Â |
Total distinct peptides | 13,779 | 100.00 |
Distinct peptides mapped to human genome | 13,461 | 97.69 |
Possible proteins implicated in mapping | 10,674 | Â |
Simple reduced proteins | 4,084 | Â |
Simple reduced genes | 3,580 | Â |
Unambiguously mapped proteins | 1,590 | Â |
Total distinct peptides, presented in ≥2 samples | 9,170 | 66.55 |
Total singleton distinct peptides | 4,609 | 33.45 |
Cys-containing distinct peptides | 3,709 | 26.92 |
Trp-containing distinct peptides | 2,067 | 15.00 |
Lys-containing distinct peptides | 8,392 | 60.90 |
Total distinct peptides from colon cancer versus normal | 5,958 | Â |
Total distinct peptides from breast cancer versus normal | 8,874 | Â |
Total distinct peptides from pancreatic cancer versus normal | 7,753 | Â |
Total distinct peptides from ovarian cancer versus normal | 5,368 | Â |
Total distinct peptides in all four reference sets | 2,897 | 21.02 |
Total distinct peptides in three reference sets | 1,534 | 11.13 |
Total distinct peptides in two reference sets | 2,415 | 17.53 |